Evidence map›Paper›PMID 28487634›Full record

ArticleFrontiers in molecular neuroscience2017

RyR2-Mediated Ca

Carol D SanMartín, Pablo Veloso, Tatiana Adasme, Pedro Lobos, Barbara Bruna, Jose Galaz, Alejandra García, Steffen Hartel, Cecilia Hidalgo, Andrea C Paula-Lima

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 52 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Amyloid β-Oligomers Inhibit the Nuclear CaAntioxidants (Basel, Switzerland) · 2023
    Article
  15. Cytosolic calcium: Judge, jury and executioner of neurodegeneration in Alzheimer's disease and beyond.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2023
    Review
  16. Potential mechanisms underlying lithium treatment for Alzheimer's disease and COVID-19.European review for medical and pharmacological sciences · 2022
    Review
  17. Review
  18. Article
  19. Dantrolene repurposed to treat sepsis or septic shock and COVID-19 patients.European review for medical and pharmacological sciences · 2021
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Carol D SanMartínDepartment of de Neurology and Neurosurgery, Clinical Hospital Universidad de ChileSantiago, Chile.
Pablo VelosoBiomedical Neuroscience Institute, Faculty of Medicine, Universidad de ChileSantiago, Chile.
Tatiana AdasmeBiomedical Neuroscience Institute, Faculty of Medicine, Universidad de ChileSantiago, Chile.
Pedro LobosBiomedical Neuroscience Institute, Faculty of Medicine, Universidad de ChileSantiago, Chile.
Barbara BrunaBiomedical Neuroscience Institute, Faculty of Medicine, Universidad de ChileSantiago, Chile.
Jose GalazBiomedical Neuroscience Institute, Faculty of Medicine, Universidad de ChileSantiago, Chile.
Alejandra GarcíaBiomedical Neuroscience Institute, Faculty of Medicine, Universidad de ChileSantiago, Chile.
Steffen HartelBiomedical Neuroscience Institute, Faculty of Medicine, Universidad de ChileSantiago, Chile.
Cecilia HidalgoBiomedical Neuroscience Institute, Faculty of Medicine, Universidad de ChileSantiago, Chile.
Andrea C Paula-LimaBiomedical Neuroscience Institute, Faculty of Medicine, Universidad de ChileSantiago, Chile.
University of Chile · CLHospital Clínico de la Universidad de Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amyloid β peptide oligomers (AβOs), toxic aggregates with pivotal roles in Alzheimer's disease, trigger persistent and low magnitude Ca

Indexed as

Alzheimer’s diseaseantioxidantsendoplasmic reticulummitochondrial calciumreactive oxygen species

Identifiers

PMID28487634
PMCPMC5403897
OpenAlexW2608235593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.